GRAIL to Present at Jefferies Global Healthcare Conference 2025
GRAIL (NASDAQ: GRAL), a healthcare company focused on early cancer detection, has announced its participation in the upcoming Jefferies Global Healthcare Conference 2025. The company's management will deliver a presentation on Tuesday, June 4 at 11:40 a.m. ET in New York. Investors and interested parties can access both live and replay webcasts of the presentation through GRAIL's investor relations website at investors.grail.com. The webcast recording will remain available for a minimum of 30 days following the event.
GRAIL (NASDAQ: GRAL), un'azienda sanitaria specializzata nella diagnosi precoce del cancro, ha annunciato la sua partecipazione alla prossima Jefferies Global Healthcare Conference 2025. Il management dell'azienda terr脿 una presentazione marted矛 4 giugno alle 11:40 ET a New York. Investitori e interessati potranno seguire la diretta streaming e le repliche della presentazione tramite il sito web delle relazioni con gli investitori di GRAIL all'indirizzo investors.grail.com. La registrazione del webcast rester脿 disponibile per almeno 30 giorni dopo l'evento.
GRAIL (NASDAQ: GRAL), una empresa de salud enfocada en la detecci贸n temprana del c谩ncer, ha anunciado su participaci贸n en la pr贸xima Jefferies Global Healthcare Conference 2025. La direcci贸n de la compa帽铆a realizar谩 una presentaci贸n el martes 4 de junio a las 11:40 a.m. ET en Nueva York. Los inversores y personas interesadas podr谩n acceder a las transmisiones en vivo y a las repeticiones a trav茅s del sitio web de relaciones con inversores de GRAIL en investors.grail.com. La grabaci贸n del webcast estar谩 disponible por un m铆nimo de 30 d铆as despu茅s del evento.
GRAIL(雮橃姢雼�: GRAL)電� 臁瓣赴 鞎� 歆勲嫧鞐� 欷戩爯鞚� 霊� 項姢旒�鞏� 旮办梾鞙茧, 雼り皜鞓る姅 Jefferies Global Healthcare Conference 2025鞐� 彀胳棳頃� 瓴冹澊霛缄碃 氚滍憸頄堨姷雼堧嫟. 須岇偓 瓴届榿歆勳潃 6鞗� 4鞚� 頇旍殧鞚� 鞓れ爠 11鞁� 40攵�(霃欕秬鞁滉皠) 雺挫殨鞐愳劀 氚滍憸毳� 歆勴枆頃� 鞓堨爼鞛呺媹雼�. 韴瀽鞛� 氚� 甏�鞁� 鞛堧姅 攵勲摛鞚� GRAIL 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼 investors.grail.com鞚� 韱淀暣 靸濎瓿� 氚� 雼れ嫓氤搓赴 鞗轨簮鞀ろ姼毳� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟. 鞗轨簮鞀ろ姼 雲鬼檾電� 頄夓偓 頉� 斓滌唽 30鞚缄皠 鞝滉车霅╇媹雼�.
GRAIL (NASDAQ : GRAL), une entreprise de sant茅 sp茅cialis茅e dans la d茅tection pr茅coce du cancer, a annonc茅 sa participation 脿 la prochaine Jefferies Global Healthcare Conference 2025. La direction de la soci茅t茅 pr茅sentera le mardi 4 juin 脿 11h40 ET 脿 New York. Les investisseurs et les parties int茅ress茅es pourront acc茅der aux webcasts en direct et en replay via le site des relations investisseurs de GRAIL 脿 l'adresse investors.grail.com. L'enregistrement du webcast restera disponible pendant au moins 30 jours apr猫s l'茅v茅nement.
GRAIL (NASDAQ: GRAL), ein Gesundheitsunternehmen, das sich auf die fr眉hzeitige Krebsdiagnose spezialisiert hat, hat seine Teilnahme an der bevorstehenden Jefferies Global Healthcare Conference 2025 angek眉ndigt. Das Management des Unternehmens wird am Dienstag, den 4. Juni um 11:40 Uhr ET in New York eine Pr盲sentation halten. Investoren und Interessierte k枚nnen sowohl Live- als auch Wiederholungswebcasts der Pr盲sentation 眉ber die Investor-Relations-Website von GRAIL unter investors.grail.com verfolgen. Die Aufzeichnung des Webcasts wird mindestens 30 Tage nach der Veranstaltung verf眉gbar bleiben.
- None.
- None.
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at . The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit .
View original content to download multimedia:
SOURCE GRAIL, Inc.
FAQ
When is GRAIL (GRAL) presenting at the Jefferies Global Healthcare Conference 2025?
How can investors watch GRAIL's (GRAL) presentation at the Jefferies Healthcare Conference?
How long will GRAIL's (GRAL) Jefferies Conference presentation replay be available?
What is GRAIL's (GRAL) main business focus?
